This topic contains a solution. Click here to go to the answer

Author Question: A factor to be considered in discriminating normal anxiety from abnormal anxiety is A) the type ... (Read 71 times)

tiara099

  • Hero Member
  • *****
  • Posts: 588
A factor to be considered in discriminating normal anxiety from abnormal anxiety is
 
  A) the type of object feared.
   B) the genetic component.
   C) the patient's response to medication.
   D) functional impairment.

Question 2

Object relations theory proposes that people have a basic drive for
 
  A) dominating others.
   B) satisfying sexual instincts.
   C) engaging in social interactions.
   D) spiritual development.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nmyers

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

D

Answer to Question 2

C




tiara099

  • Member
  • Posts: 588
Reply 2 on: Jun 22, 2018
Gracias!


robbielu01

  • Member
  • Posts: 336
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Approximately 500,000 babies are born each year in the United States to teenage mothers.

Did you know?

It is widely believed that giving a daily oral dose of aspirin to heart attack patients improves their chances of survival because the aspirin blocks the formation of new blood clots.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library